Trial NCT03925428

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2019-02419
Secondary IDs: 10244 NCI-2019-02419 UM1CA186689

Last trial update was posted on 2020-09-28

MeSH Interventions

Entinostat Histone Deacetylase Inhibitors

MeSH Conditions

Carcinoma Lymphoma Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Neoplasms Pancreatic Neoplasms

Other Conditions

Advanced Lymphoma Advanced Malignant Solid Neoplasm Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage IV T-Cell Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Pancreatic Carcinoma Refractory T-Cell Non-Hodgkin Lymphoma Stage II Pancreatic Cancer AJCC v8 Stage IIA Pancreatic Cancer AJCC v8 Stage IIB Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Pancreatic Carcinoma

Stopping Reasons

Other - Protocol moved to Disapproved

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID